Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Local Manufacturers Drive New Initiative to Boost East Africa’s Medical Oxygen Supply 22/10/2024 Kerry Cullinan A sod-turning ceremony in Mombasa, Kenya, on Tuesday marked the launch of the East African Programme on Oxygen Access (EAPOA), which aims to massively boost access to medical oxygen in the region. Unitaid is investing $22 million in support for Kenyan manufacturers Hewatele and Synergy, and Tanzania Oxygen Limited to set up Africa’s first liquid […] Continue reading -> World Can Halve Premature Deaths by 2050, Lancet Commission Reports 15/10/2024 Stefan Anderson BERLIN – Countries worldwide, regardless of income level, can halve premature death rates by 2050, a new Lancet report presented at the closing of the World Health Summit in Berlin suggests. Fifteen key health threats are driving premature deaths worldwide, with tobacco use leading the pack “by far”, the Lancet Commission for Investing in Health […] Continue reading -> Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Local Manufacturers Drive New Initiative to Boost East Africa’s Medical Oxygen Supply 22/10/2024 Kerry Cullinan A sod-turning ceremony in Mombasa, Kenya, on Tuesday marked the launch of the East African Programme on Oxygen Access (EAPOA), which aims to massively boost access to medical oxygen in the region. Unitaid is investing $22 million in support for Kenyan manufacturers Hewatele and Synergy, and Tanzania Oxygen Limited to set up Africa’s first liquid […] Continue reading -> World Can Halve Premature Deaths by 2050, Lancet Commission Reports 15/10/2024 Stefan Anderson BERLIN – Countries worldwide, regardless of income level, can halve premature death rates by 2050, a new Lancet report presented at the closing of the World Health Summit in Berlin suggests. Fifteen key health threats are driving premature deaths worldwide, with tobacco use leading the pack “by far”, the Lancet Commission for Investing in Health […] Continue reading -> Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Local Manufacturers Drive New Initiative to Boost East Africa’s Medical Oxygen Supply 22/10/2024 Kerry Cullinan A sod-turning ceremony in Mombasa, Kenya, on Tuesday marked the launch of the East African Programme on Oxygen Access (EAPOA), which aims to massively boost access to medical oxygen in the region. Unitaid is investing $22 million in support for Kenyan manufacturers Hewatele and Synergy, and Tanzania Oxygen Limited to set up Africa’s first liquid […] Continue reading -> World Can Halve Premature Deaths by 2050, Lancet Commission Reports 15/10/2024 Stefan Anderson BERLIN – Countries worldwide, regardless of income level, can halve premature death rates by 2050, a new Lancet report presented at the closing of the World Health Summit in Berlin suggests. Fifteen key health threats are driving premature deaths worldwide, with tobacco use leading the pack “by far”, the Lancet Commission for Investing in Health […] Continue reading -> Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Local Manufacturers Drive New Initiative to Boost East Africa’s Medical Oxygen Supply 22/10/2024 Kerry Cullinan A sod-turning ceremony in Mombasa, Kenya, on Tuesday marked the launch of the East African Programme on Oxygen Access (EAPOA), which aims to massively boost access to medical oxygen in the region. Unitaid is investing $22 million in support for Kenyan manufacturers Hewatele and Synergy, and Tanzania Oxygen Limited to set up Africa’s first liquid […] Continue reading -> World Can Halve Premature Deaths by 2050, Lancet Commission Reports 15/10/2024 Stefan Anderson BERLIN – Countries worldwide, regardless of income level, can halve premature death rates by 2050, a new Lancet report presented at the closing of the World Health Summit in Berlin suggests. Fifteen key health threats are driving premature deaths worldwide, with tobacco use leading the pack “by far”, the Lancet Commission for Investing in Health […] Continue reading -> Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Local Manufacturers Drive New Initiative to Boost East Africa’s Medical Oxygen Supply 22/10/2024 Kerry Cullinan A sod-turning ceremony in Mombasa, Kenya, on Tuesday marked the launch of the East African Programme on Oxygen Access (EAPOA), which aims to massively boost access to medical oxygen in the region. Unitaid is investing $22 million in support for Kenyan manufacturers Hewatele and Synergy, and Tanzania Oxygen Limited to set up Africa’s first liquid […] Continue reading -> World Can Halve Premature Deaths by 2050, Lancet Commission Reports 15/10/2024 Stefan Anderson BERLIN – Countries worldwide, regardless of income level, can halve premature death rates by 2050, a new Lancet report presented at the closing of the World Health Summit in Berlin suggests. Fifteen key health threats are driving premature deaths worldwide, with tobacco use leading the pack “by far”, the Lancet Commission for Investing in Health […] Continue reading -> Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Can Halve Premature Deaths by 2050, Lancet Commission Reports 15/10/2024 Stefan Anderson BERLIN – Countries worldwide, regardless of income level, can halve premature death rates by 2050, a new Lancet report presented at the closing of the World Health Summit in Berlin suggests. Fifteen key health threats are driving premature deaths worldwide, with tobacco use leading the pack “by far”, the Lancet Commission for Investing in Health […] Continue reading -> Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Update on the mRNA Technology Transfer Programme 11/10/2024 Medicines Patent Pool & World Health Organization A recent article published by HPW based on research by Matthew Herder and Ximena Benavides made several criticisms and observations about the mRNA programme. HPW asked the mRNA co-leaders, the MPP and WHO, to respond to the issues raised and this is their response. The mRNA Technology Transfer Programme, established by the World Health Organization […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Big Wins – And Challenges – For Global Fund in Tackling HIV, TB and Malaria 19/09/2024 Kerry Cullinan Global Fund investments have reduced deaths in HIV, tuberculosis and malaria by 61% and saved 65 million lives since 2002 – while simultaneously improving health service delivery, according to its annual Results Report released on Thursday. The past year (2023) has brought significant wins: a 55% reduction in the price of bedaquiline, the main treatment […] Continue reading -> How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Strong Pharmaceutical Systems Can Prevent the Spread of Superbugs 04/09/2024 Francis Aboagye-Nyame When policymakers, advocates, diplomats, and practitioners come together this month at the UN General Assembly, drug-resistant superbugs will be on everyone’s mind. Antimicrobial resistance (AMR), the phenomenon where bacteria and other infectious agents no longer respond to treatments, will be the topic of a UN High-Level Meeting on 26 September to discuss this serious and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy